Home ›
Organizations ›
TOWER CANCER RESEARCH FOUNDATION
TOWER CANCER RESEARCH FOUNDATION
CA · Medical Research · EIN 954596354
6
Executives Disclosed
$3.1M
Annual Revenue
$3.2M
Total Assets
1.5:1
Internal Pay Ratio
TOWER CANCER RESEARCH FOUNDATION has 6 executives with disclosed compensation. The highest-paid executive, Christopher Clinton Conway (EXECUTIVE DIRECTOR), received peak total compensation of $295,587. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Christopher Clinton Conway | EXECUTIVE DIRECTOR | $296K | $296K | 2024–2024 | 3.9x |
| Linda David | EXECUTIVE DIRECTOR (THRU 1/5) | $250K | $0 | 2016–2024 | 3.3x |
| Steven Abramson | EXECUTIVE DIRECTOR (THRU 9/30/23) | $195K | $195K | 2022–2023 | 2.6x |
| Ann Spurgeon | CDO | $133K | $0 | 2022–2022 | 1.8x |
| Kelli Sargent | DEPUTY DIRECTOR | $119K | $0 | 2022–2023 | 1.6x |
| James Surmeian | DIRECTOR OF ADMINISTRATION AND FINANCE | $101K | $0 | 2018–2018 | 1.3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 1 | $197K | $197K | $197K |
| 2017 | 1 | $205K | $205K | $205K |
| 2018 | 2 | $234K | $234K | $234K |
| 2019 | 1 | $250K | $250K | $250K |
| 2020 | 1 | $246K | $246K | $246K |
| 2021 | 1 | $248K | $248K | $248K |
| 2022 | 4 | $208K | $208K | $208K |
| 2023 | 3 | $195K | $195K | $195K |
| 2024 | 2 | $296K | $296K | $296K |
Email Alerts
Get notified about TOWER CANCER RESEARCH FOUNDATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.